Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · IEX Real-Time Price · USD
0.880
+0.043 (5.16%)
May 31, 2024, 4:00 PM EDT - Market closed
Unicycive Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for UNCY stock have an average target of 5.50, with a low estimate of 3.00 and a high estimate of 9.00. The average target predicts an increase of 525.00% from the current stock price of 0.88.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for UNCY stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 2 | 2 | 2 |
Buy | 1 | 1 | 2 | 2 | 3 | 3 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 5 | 4 | 5 | 5 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Benchmark | Benchmark | Buy Reiterates $3 | Buy | Reiterates | $3 | +240.91% | May 31, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4.5 | Strong Buy | Reiterates | $4.5 | +411.36% | May 29, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4.5 | Strong Buy | Reiterates | $4.5 | +411.36% | May 14, 2024 |
Benchmark | Benchmark | Buy Reiterates $3 | Buy | Reiterates | $3 | +240.91% | Apr 15, 2024 |
Piper Sandler | Piper Sandler | Buy Initiates $9 | Buy | Initiates | $9 | +922.73% | Apr 4, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
36.91M
EPS This Year
-1.12
from -1.28
EPS Next Year
-0.26
from -1.12
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | 123.4M | 522.5M | 1.2B | 461.3M |
Avg | n/a | 36.9M | 243.7M | 432.9M | 272.7M |
Low | n/a | 2.0M | 19.3M | 37.5M | 60.2M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | 1,315.8% | 390.4% | 6.6% |
Avg | - | - | 560.2% | 77.7% | -37.0% |
Low | - | - | -47.7% | -84.6% | -86.1% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.59 | 0.71 | 5.11 | 10.74 | 2.93 |
Avg | -1.12 | -0.26 | 1.64 | 3.44 | 1.26 |
Low | -1.49 | -0.79 | -0.53 | -0.31 | 0.31 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | 554.1% | -14.9% |
Avg | - | - | - | 109.5% | -63.3% |
Low | - | - | - | - | -90.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.